# Milan Patel

> Milan Patel is the co-founder and CEO of Scottsdale-based PathogenDx, where he translates multiplexed microarray science into practical pathogen-testing products for food, agriculture and laboratory customers. Born in Kenya, raised in London after arriving in the United Kingdom as a refugee, and educated in engineering and business in the United States, Patel brought experience from automotive development, electronics manufacturing, Intel, government-services finance and biotech operations to a company built around turning research into usable tools.

- **Role:** CEO and Co-Founder at PathogenDx
- **Organizations:** PathogenDx, GMSBiotech, 2020 Company, LLC, Intel Corporation, Acentia, CollabraLink Technologies
- **From:** Kenya
- **Education:** Bachelor's degree in Electrical Engineering, University of Detroit Mercy, Master of Business Administration, University of Detroit Mercy, Master's degree in Biomedical Engineering, University of Michigan
- **Known for:** Co-founded PathogenDx in 2014 and led its commercialization strategy and operations., Helped translate licensed microarray research into testing kits, automation and software for food and agricultural laboratories., Led PathogenDx through its first commercial revenue, first 100 customers and the FDA emergency authorization milestone described in a 2022 interview.

## Career timeline

- **1987-1991** — Studied at the University of Detroit Mercy, including a bachelor's degree in electrical engineering.
- **1990s** — Worked in the automotive industry on Team Mustang, ran an electronics manufacturing company and later joined Intel, where he worked across technology and finance.
- **2006** — Became CFO of 2020 Company, LLC, working with founders Paresh Ghelani and Haresh Bhungalia.
- **Before 2014** — Served as COO/CFO of GMSBiotech, a diagnostics company focused on microarray technology.
- **2012** — Joined the parent company whose technology would later be licensed to PathogenDx.
- **2014** — Co-founded PathogenDx to commercialize licensed microarray technology for pathogen testing.
- **2020** — PathogenDx introduced a food-safety assay designed to support preventive environmental monitoring without enrichment.
- **2021** — PathogenDx launched a live-versus-dead sample-processing approach for regulated cannabis microbial testing.
- **2023** — Discussed standardizing cannabis testing on the Octa automated platform and a common workflow across differing state regulations.
- **2026** — PathogenDx launched a unified poultry testing system at IPPE, combining Salmonella detection, quantitation, serotyping and vaccine identification.

## Achievements

- Co-founded PathogenDx in 2014 and led its commercialization strategy and operations.
- Helped translate licensed microarray research into testing kits, automation and software for food and agricultural laboratories.
- Led PathogenDx through its first commercial revenue, first 100 customers and the FDA emergency authorization milestone described in a 2022 interview.
- Helped grow 2020 Company, LLC from roughly $5-6 million to $75 million in revenue before its sale, according to his 2023 interview.
- PathogenDx's environmental and cannabis assays have received AOAC Performance Tested Methods certifications.
- Oversaw PathogenDx's 2026 launch of a unified Salmonella testing system for poultry operations.

## Latest updates

- **2026-08** — PathogenDx published its takeaways from IAFP 2026, positioning its unified poultry portfolio around data-driven Salmonella process control.
- **2026-06** — PathogenDx highlighted research on differing Salmonella transmission patterns and argued for practical, higher-resolution serotyping in poultry operations.
- **2026-01** — PathogenDx launched its Unified Salmonella Testing System at IPPE 2026, with Milan Patel emphasizing tools designed for real production facilities and different processor sizes.
- **2024-02** — PathogenDx announced D3 Array-UTI, a multiplexed molecular test with automated cloud-based analysis and reporting.

## Links

- Website: https://pathogendx.com
- LinkedIn: https://www.linkedin.com/in/milan-patel-ceo
- Twitter/X: https://twitter.com/PathogenDX
- Instagram: https://www.instagram.com/pathogen_dx/
- Facebook: https://www.facebook.com/PathogenDx

---

Profile page: https://yespress.io/milan-patel
Published by YesPress — https://yespress.io
Last updated: 2026-08-27